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The purpose of this study is to determine a specific enhancer to increase the skin 
permeation of only lipophilic or hydrophilic drugs. Seven kinds of enhancers were evaluat-
ed about the specificity or selectivit_v of their skin permeation-enhancing effects by an in 
vitro permeation study using 2-chamber diffusion cells and excised hairless rat skin. 
Isosorbide dinitrate and antipyrine were used as models for typical lipophilic and hydro-
philic drugs. The enhancement factors were calculated by dividing the obtained steady-
state fiux of the drugs with each enhancer by that without enhancer (controD , and the 
specificity of the enhancers was evaluated using these factors. As a result, the effect of each 
enhancer was greatly related to the lipophilicity of the drugs. The enhancers were 
therefore divided by the values of the factors into type I enhancers, which specially 
increased the skin permeation of the lipophilic drug isosorbide dinitrate such as lauric acid 
and lauryl alcoho] ; type 2 enhancers, which promoted the permeation of the hydrophilic 
drug antipyrine such as a-terpineol, l-menthol and N-methyl-2-pyrrolidone ; and type 3 
enhancers, which enhanced the permeation of both drugs such as isopropyl myristate and 
AzoneR. The difference in the specificity in the enhancing effects might be the result of the 
skin permeation-enhancing mechanism. The mechanism may be related to structural 
properties of the enhancers rather than their physicochemical characteristics. 
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